How Inven2 work with securing IPR: strategies and challenges in the field of oncology, Kirsten Stangeby, IPR Manager and Mohammed Amarzguioui, Technology Strategy Manager, both at Inven2.

/in , /by

How Inven2 work with securing IPR: strategies and challenges in the field of oncology, Kirsten Stangeby, IPR Manager and Mohammed Amarzguioui, Technology Strategy Manager, both at Inven2.

How Inven2 work with securing IPR: strategies and challenges in the field of oncology, Kirsten Stangeby, IPR Manager and Mohammed Amarzguioui, Technology Strategy Manager, both at Inven2.

What can be patented, how to proceed and what is absolutely crucial in the process? Elen Margrethe Brendeford, Patent examiner, Norwegian Industrial Property Office

/in , /by

What can be patented, how to proceed and what is absolutely crucial in the process? Elen Margrethe Brendeford, Patent examiner, Norwegian Industrial Property Office

What can be patented, how to proceed and what is absolutely crucial in the process? Elen Margrethe Brendeford, Patent examiner, Norwegian Industrial Property Office

Why is it important to protect your oncology innovation? Bjørn Lillekjendlie, Director Patent department, Norwegian Industrial Property Office (Patentstyret)

/in , /by

Why is it important to protect your oncology innovation? Bjørn Lillekjendlie, Director Patent department, Norwegian Industrial Property Office (Patentstyret)

Why is it important to protect your oncology innovation? Bjørn Lillekjendlie, Director Patent department, Norwegian Industrial Property Office (Patentstyret)